ABVC BioPharma Inc. (ABVC)
NASDAQ: ABVCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ABVC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $26.69M
- EPS (TTM)
- -$0.30
- Dividend yield
- None
- 52-week range
- 0.707 – 3.33
- Day range
- 0.94 – 1.01
- Volume / Avg
- 52.74K / 119.85K
- Beta
- —
- Shares outstanding
- 26.69M
- Next earnings
- Oct 30, 2026
52-week range
ABVC stock today
ABVC BioPharma (ABVC) closed at $1.00 on Oct 7, up 3.09% (+$0.03), versus the S&P 500's 0.22% decline. Trading was light, with 52.74K shares changing hands, about 44% of the average daily volume. At this level, ABVC sits near the bottom of its 52-week range of $0.707 to $3.33: 70.0% below the high and 41.4% above the low.
ABVC is down 53.1% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 68.9%. ABVC BioPharma has posted a net loss over the last twelve months (EPS of -$0.30), so its P/E ratio is not meaningful. ABVC BioPharma's next earnings report is expected on Oct 30, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About ABVC BioPharma
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Earnings
Earnings history- Next report
- Oct 30, 2026
ABVC BioPharma peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BYSIBeyondSpring Inc. | 0.6445 | -6.90% | $26.50M | vs ABVC |
| MCRBSeres Therapeutics Inc. | 2.72 | -6.21% | $27.32M | vs ABVC |
| KYNBKyntra Bio Inc. | 6.13 | +2.85% | $24.82M | vs ABVC |
| CNTXContext Therapeutics Inc. | 0.3126 | -2.86% | $28.72M | vs ABVC |
| ATOSAtossa Therapeutics Inc. | 2.46 | +0.41% | $24.55M | vs ABVC |
| IGCIGC Pharma Inc. | 0.28 | 0.00% | $28.95M | vs ABVC |
| GRDXGridAI Technologies Corp. | 4.12 | -1.20% | $29.38M | vs ABVC |
| RNAZTransCode Therapeutics Inc. | 1.76 | -1.12% | $29.80M | vs ABVC |
Indexes, lists and sector
ABVC BioPharma stock FAQ
What is ABVC BioPharma's stock price today?
ABVC last traded at $1.00 as of Oct 7, 4:00 PM EDT, up 3.09% on the day. Prices are delayed at least 15 minutes.
Does ABVC BioPharma pay a dividend?
No. ABVC BioPharma does not currently pay a regular cash dividend.
When is ABVC BioPharma's next earnings date?
ABVC BioPharma is expected to report earnings on Friday, October 30, 2026.
Has ABVC ever split its stock?
Yes. The most recent ABVC stock split was a 1-for-10 split on Jul 25, 2023, one of 6 splits on record.
What is the ABVC 52-week high?
The 52-week high for ABVC is $3.33 and the 52-week low is $0.707. The stock is currently 70.0% below its high.